Syndax Pharmaceuticals (SNDX) PT Raised to $20 at Goldman Sachs

August 5, 2025 5:12 AM

Goldman Sachs analyst Corinne Johnson raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $20.00 (from $18.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found